Paper38005286
HA-Coated PLGA Nanoparticles Loaded with Apigenin for Colon Cancer with High Expression of CD44.
Yang B and 6 others. Molecules, 2023. Cited by 18 papers, by iCite.
Cite this record
ConductScience Library. HA-Coated PLGA Nanoparticles Loaded with Apigenin for Colon Cancer with High Expression of CD44. Papers, record 38005286. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38005286
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- HA-Coated PLGA Nanoparticles Loaded with Apigenin for Colon Cancer with High Expression of CD44.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Nanoparticles | Major topic |
| Colonic Neoplasms | Major topic |
| Animals | |
| Mice | |
| Hyaluronic Acid | |
| Apigenin | |
| Mice, Nude | |
| Drug Carriers | |
| Cell Line, Tumor |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2020CX41 | Harbin University of Commerce Youth Top Talent Program | PubMed |
Source PubMed
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33970845 | Effect of Modifications in Poly (Lactide-co-Glycolide) (PLGA) on Drug Release and Degradation Characteristics: A Mini Review. | Curr Drug Deliv | 2021 | https://conductscience.org/library/papers/33970845 | PubMed |
| 2 | 35216149 | PLGA-Based Composites for Various Biomedical Applications. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35216149 | PubMed |
| 3 | 30875872 | The Therapeutic Potential of Apigenin. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/30875872 | PubMed |
| 4 | 37655476 | Multifunctional GQDs for receptor targeting, drug delivery, and bioimaging in pancreatic cancer. | Nanoscale | 2023 | https://conductscience.org/library/papers/37655476 | PubMed |
| 5 | 35998830 | Apigenin and its dermatological applications: A comprehensive review. | Phytochemistry | 2022 | https://conductscience.org/library/papers/35998830 | PubMed |
| 6 | 34184949 | PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application. | Drug Deliv | 2021 | https://conductscience.org/library/papers/34184949 | PubMed |
| 7 | 29680738 | Inhibition of PI3K/Akt/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cells. | Biomed Pharmacother | 2018 | https://conductscience.org/library/papers/29680738 | PubMed |
| 8 | 32517278 | Hyaluronic Acid and Controlled Release: A Review. | Molecules | 2020 | https://conductscience.org/library/papers/32517278 | PubMed |
| 9 | 16640493 | Nanoparticle-aptamer bioconjugates for cancer targeting. | Expert Opin Drug Deliv | 2006 | https://conductscience.org/library/papers/16640493 | PubMed |
| 10 | 22584163 | α(V)β(3) integrin-targeted PLGA-PEG nanoparticles for enhanced anti-tumor efficacy of a Pt(IV) prodrug. | ACS Nano | 2012 | https://conductscience.org/library/papers/22584163 | PubMed |
| 11 | 35752426 | Apigenin in cancer prevention and therapy: A systematic review and meta-analysis of animal models. | Crit Rev Oncol Hematol | 2022 | https://conductscience.org/library/papers/35752426 | PubMed |
| 12 | 35164326 | Hyaluronated and PEGylated Liposomes as a Potential Drug-Delivery Strategy to Specifically Target Liver Cancer and Inflammatory Cells. | Molecules | 2022 | https://conductscience.org/library/papers/35164326 | PubMed |
| 13 | 29116098 | Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy. | Sci Rep | 2017 | https://conductscience.org/library/papers/29116098 | PubMed |
| 14 | 27919215 | Current Strategies in the Modification of PLGA-based Gene Delivery System. | Curr Med Chem | 2017 | https://conductscience.org/library/papers/27919215 | PubMed |
| 15 | 26961463 | Cellular distribution of injected PLGA-nanoparticles in the liver. | Nanomedicine | 2016 | https://conductscience.org/library/papers/26961463 | PubMed |
| 16 | 29554416 | Hyaluronic Acid/Chitosan Coacervate-Based Scaffolds. | Biomacromolecules | 2018 | https://conductscience.org/library/papers/29554416 | PubMed |
| 17 | 27766890 | Pharmacokinetic properties and drug interactions of apigenin, a natural flavone. | Expert Opin Drug Metab Toxicol | 2017 | https://conductscience.org/library/papers/27766890 | PubMed |
| 18 | 33683499 | Synthetic Receptor-Based Targeting Strategies to Improve Tumor Drug Delivery. | AAPS PharmSciTech | 2021 | https://conductscience.org/library/papers/33683499 | PubMed |
| 19 | 26453158 | Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine. | J Drug Target | 2015 | https://conductscience.org/library/papers/26453158 | PubMed |
| 20 | 29097249 | Apigenin: A dietary flavonoid with diverse anticancer properties. | Cancer Lett | 2018 | https://conductscience.org/library/papers/29097249 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42936725 | Bioactive Polysaccharide-Phytochemical Supramolecular Co-Assemblies for Carrier-Free and Carrier-Minimized Nanomedicine: Design Principles and Translational Challenges. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42936725 | PubMed |
| 42675095 | Nanoparticle-enhanced apigenin suppresses androgen receptor signaling and cellular plasticity in LNCaP cells. | Sci Rep | 2026 | https://conductscience.org/library/papers/42675095 | PubMed |
| 42524089 | Apigenin as a Multi-Targeted Agent in Gastrointestinal Cancers: A Systems Pharmacology Approach. | Adv Pharm Bull | 2026 | https://conductscience.org/library/papers/42524089 | PubMed |
| 42365116 | Unveiling the potential of solid lipid nanoparticles of apigenin-Cu(II) coordinated nanocomplex in colon cancer. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/42365116 | PubMed |
| 41939211 | Natural Polymers Based Biocompatible Nanomedicines for Targeting Colon Cancer: Prospects and Challenges. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/41939211 | PubMed |
| 41440901 | Chitosan-Based Drug Delivery Systems for Targeted Chemotherapy in Colorectal Cancer: A Scoping Review. | Mar Drugs | 2025 | https://conductscience.org/library/papers/41440901 | PubMed |
| 40859950 | Combined Hyaluronic Acid Nanobioconjugates Impair CD44-Signaling for Effective Treatment Against Obesity: A Review of Comparison with Other Actors. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/40859950 | PubMed |
| 40788176 | Unlocking the full potential of piperine-loaded nanocarriers for cancer treatment. | Ther Deliv | 2025 | https://conductscience.org/library/papers/40788176 | PubMed |
| 40561797 | Targeting drug resistant colorectal cancer with apigenin nanoarchitectures. | Transl Oncol | 2025 | https://conductscience.org/library/papers/40561797 | PubMed |
| 40006045 | Flavonoids and Flavonoid-Based Nanopharmaceuticals as Promising Therapeutic Strategies for Colorectal Cancer-An Updated Literature Review. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40006045 | PubMed |
| 39686635 | An Updated Review Deciphering Apigenin Nanostructures as Promising Therapeutic Efficiency in Human Carcinomas. | Curr Med Chem | 2025 | https://conductscience.org/library/papers/39686635 | PubMed |
| 39416904 | Nature's weapons: Bioactive compounds as anti-cancer agents. | AIMS Public Health | 2024 | https://conductscience.org/library/papers/39416904 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AVPR2 | 554 | PubTator's text mining | https://conductscience.org/library/genes/554 | NCBI Gene |
| CD44 | 960 | PubTator's text mining | https://conductscience.org/library/genes/960 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38005286
GET https://conductscience.org/api/papers/v1/38005286/references?page=2